4 results

• Savaysa Side Effects May Carry Higher Risk of Bleeding Than Warfarin For Heart Valve Replacement Patients: Study

  September 1, 2021

  Irvin Jackson

  A new study indicates the blood thinner Savaysa increases the risk of gastrointestinal bleeding for TAVR patients with atrial fibrillation when compared to warfarin.

• Reversal Agent for Uncontrollable Xarelto Bleeding Delayed by FDA

  August 22, 2016

  Irvin Jackson

  A proposed reversal agent for the blood thinners Xarelto and Eliquis suffered a setback this week when the FDA rejected its approval, asking questions about manufacturing and its potential use with similar drugs.

• Savaysa, New Factor Xa Blood Thinner, To Hit Market With Black Box Warning

  February 9, 2015

  Irvin Jackson

  A new blood thinner approved by the FDA carries a black box warning that it may be less effective in patients with normal kidney functions.

• Xarelto Antidote to Reverse Bleeding Problems May Have Been Found by Portola

  January 12, 2015

  Irvin Jackson

  Clinical trials have shown some success in the development for a Xarelto reversal agent, as manufacturers race to develop antidotes for blood thinners linked to deadly and uncontrollable bleeding problems.